{"record_key":"zegenex-inc","identifier":"zegenex-inc","external_key":"C2013D","title":"Zegenex Inc.","summary":null,"url":"https://inventions.pitt.edu/startups/zegenex-inc","json_url":"https://inventions.pitt.edu/startups/zegenex-inc.json","object_key":"startups","description":"Zegenex is developing topical treatments to help persistent wounds heal. Built on University of Pittsburgh research and licensed technology, its small-molecule platform is designed to reactivate the body's tissue-repair processes. The company's lead program focuses on diabetic foot ulcers, with potential applications in other chronic and complex wounds. [1]: https://zegenex.com/\nCo-founded by Michael Tsang and Manush Saydmohammed, Zegenex brings regenerative biology into practical wound-care development. Its investigational formulations are designed for room-temperature storage and straightforward topical application, with the goal of making advanced wound care easier to deliver. The company is advancing its preclinical program toward human studies. [2]: https://zegenex.com/company [1]: https://zegenex.com/","attributes":[{"key":"website","label":"Website","values":["https://zegenex.com/"]},{"key":"sector","label":"Sector","values":["Therapeutics"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Dermatology"]},{"key":"founders","label":"Founders","values":["Michael Tsang","Manush Saydmohammed"]}],"related":[]}